Jatenzo® (testosterone undecanoate) is a prescription oral medication used to treat adult men who have low or no testosterone caused by certain medical conditions.
Jatenzo
*image for illustrative purpose only
Jatenzo
*image for illustrative purpose only
Jatenzo® is an oral testosterone medication that contains the androgen testosterone undecanoate. It’s used for testosterone replacement therapy (TRT) and is designed to help restore normal testosterone levels in adult men with confirmed testosterone deficiency due to medical conditions such as hypogonadism, which happens when the body does not produce enough testosterone on its own. It is not approved for age-related declines in testosterone.
Unlike injectable testosterone, Jatenzo is taken as a capsule, offering a convenient alternative for patients who prefer oral therapy. The typical starting dose of Jatenzo is 237 mg taken twice daily with food, but the dosage may be adjusted based on blood testosterone levels. The prescribed dose usually ranges between 158 mg and 396 mg twice daily.
Side effects of Jatenzo may include increased blood pressure, headaches, nausea, diarrhea, and changes in mood, such as irritability or aggression. More serious risks include cardiovascular complications like heart attack, stroke, and worsening of pre-existing hypertension (high blood pressure). Jatenzo can also increase red blood cell count, which may raise the risk of blood clots.
Jatenzo (testosterone undecanoate) is indicated for:
Testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone
Androgen
Most common adverse reactions (incidence >2%):
Polycythemia
Diarrhea
Indigestion
Belching
Peripheral swelling
Nausea
Increased hematocrit
Headache
Prostatomegaly
High blood pressure
The price of Jatenzo may vary depending on the dosage, quantity, where you buy it, and your insurance plan. The average retail price of Jatenzo is about $1,700 for a month’s supply of 237 mg capsules, but coupons and discount cards may be available to bring down the price. The drug’s manufacturer offers a copay card that allows eligible people with commercial insurance to pay as little as $0 per month for Jatenzo and those without insurance to pay $185 for a month’s supply.
There is currently no lower-cost generic version of Jatenzo available.
Jatenzo is only available by prescription from a healthcare provider. If you’re interested in taking this medication, make an appointment with your provider. They can assess your testosterone levels and discuss with you whether testosterone replacement therapy is appropriate based on factors like your health status, medical history, and symptoms.
Men with breast cancer or known or suspected prostate cancer
Women who are pregnant. Testosterone may cause fetal harm
Known hypersensitivity to Jatenzo or any of its ingredients
Men with hypogonadal conditions not associated with structural or genetic etiologies
Drug interactions: Androgens may decrease blood glucose and therefore may decrease insulin requirements in diabetic patients, changes in anticoagulant activity may be seen with androgens, use of testosterone with corticosteroids may result in increased fluid retention, concomitant administration of medications that are known to increase blood pressure may lead to additional increases in blood pressure when used with Jatenzo
Monitor hematocrit approximately every 3 months to detect increased red blood cell mass and polycythemia
Monitor patients with benign prostatic hyperplasia (BPH) for worsening of signs and symptoms of BPH
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE) have been reported in patients using testosterone
Testosterone has been subject to abuse, typically at doses higher than recommended for the approved indication and in combination with other anabolic androgenic steroids
Exogenous administration of androgens may lead to azoospermia
Edema, with or without congestive heart failure, may occur in patients with pre-existing cardiac, renal, or hepatic disease
Sleep apnea may occur in those with risk factors
Monitor prostate specific antigen (PSA) and lipid concentrations periodically
Depression and suicidal ideation have occurred during clinical trials in patients treated with Jatenzo
WARNING: INCREASES IN BLOOD PRESSURE
Jatenzo can cause blood pressure (BP) increases that can increase the risk of major adverse cardiovascular events (MACE), including non-fatal myocardial infarction, non-fatal stroke and cardiovascular death.
Before initiating Jatenzo, consider the patient's baseline cardiovascular risk and ensure blood pressure is adequately controlled.
Periodically monitor for and treat new-onset hypertension or exacerbations of pre-existing hypertension and re-evaluate whether the benefits of Jatenzo outweigh its risks in patients who develop cardiovascular risk factors or cardiovascular disease on treatment.
Due to this risk, use Jatenzo only for the treatment of men with hypogonadal conditions associated with structural or genetic etiologies.
There are other treatments for low testosterone or hypogonadism. Some treatments may be better suited to you than others. If you’re interested in trying an alternative to Jatenzo, consider connecting with a healthcare provider who can help you evaluate your options.
Other types of testosterone replacement therapy (sometimes called androgen replacement) include:
Injectable testosterone, such as Aveed®, Depo®-Testosterone, or Azmiro®
Implantable testosterone pellets, such as Testopel®
Other oral testosterone therapy medications, including Kyzatrex® and Tlando®
Topical testosterone, such as Androderm® (testosterone patch) and Testim® (testosterone gel)
Alternatives to TRT that may help manage low testosterone in men include the following, which can signal the body to have or make more testosterone:
Aromatase inhibitors like Arimidex® (anastrozole)
Human chorionic gonadotropin (hCG) or Ovidrel®, a lab-made version of hCG
Selective estrogen receptor modulators like Clomid (clomiphene)
Your healthcare provider may also prescribe non-medication alternatives that can support healthy testosterone levels, including:
Exercise
Stress management
Dietary improvements
Getting enough sleep
Weight loss
Jatenzo is a brand-name drug, which tend to be more expensive than generic drugs. Generic drugs have the same active ingredient as brand-name drugs but typically cost less because they have lower marketing and manufacturing costs. There is currently no generic form of Jatenzo available.
Unlike older forms of oral testosterone, Jatenzo is absorbed by the intestinal lymphatic system, which means it bypasses the liver. No liver toxicity was seen in the drug’s clinical trials.
In a study of more than 150 people with low testosterone who took Jatenzo, more than 87 percent saw their blood testosterone restored to normal, healthy levels within three to four months.
Typically, Jatenzo is prescribed as a twice-daily dose, but your provider may adjust your dosage over time based on your testosterone levels. Always take Jatenzo as prescribed, and never adjust your dosage without consulting your provider.
*This information is from the label for brand name Jatenzo®. See the Full Prescribing Information for more complete information. Testosterone undecanoate, the active ingredient in Jatenzo, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient testosterone undecanoate.
Edwards RZ, et al. (2020). Improving low testosterone naturally. https://www.va.gov/WHOLEHEALTHLIBRARY/docs/Improving-Low-Testosterone-Naturally.pdf
GoodRx. (n.d.). Jatenzo prices, coupons, and savings tips. https://www.goodrx.com/jatenzo/what-is
Ide V, et al. (2021). Treatment of men with central hypogonadism: alternatives for testosterone replacement therapy. https://www.mdpi.com/1422-0067/22/1/21
Jatenzo.com. (n.d.). Jatenzo FAQs: Patient resources and downloadable materials. https://jatenzo.com/resources-faqs/
National Library of Medicine. (2025). DailyMed: Jatenzo. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed7b5d41-7475-4c10-99b9-b62b3434ae60
Sizar O, et al. (2023). Androgen replacement. https://www.ncbi.nlm.nih.gov/books/NBK534853/
Swerdloff RS, et al. (2020). New oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. https://academic.oup.com/jcem/article/105/8/2515/5834353
U.S. Food & Drug Administration. (2021). Generic drugs: questions & answers. https://www.fda.gov/drugs/frequently-asked-questions-popular-topics/generic-drugs-questions-answers